Among these, AD is considered a secondary or non-primary tauopathy, although given the broad spectrum of phenotypical manifestations of the combined effect of Aβ plaques and tau inclusions, this classification is still controversial [163]. The gene discussed is MAPT; the disease is tauopathy.